IMC Chicago LLC Purchases 2,335 Shares of ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS)
IMC Chicago LLC Purchases 2,335 Shares of ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS)
ProShares Ultra Nasdaq Biotechnology (the Fund) seeks investment results for a single day only, not for longer periods. The Fund seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day's returns compounded over the period, which will very likely differ from twice (200%) the return of the Nasdaq Biotechnology Index (the Index) for that period.IMC Chicago LLC increased its position in shares of ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS – Get Rating) by 12.5% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 21,003 shares of the company's stock after acquiring an additional 2,335 shares during the period. IMC Chicago LLC owned about 5.25% of ProShares UltraShort Nasdaq Biotechnology worth $566,000 as of its most recent filing with the Securities and Exchange Commission.
IMC Chicago LLC在第二季度增加了ProShares UltraShort Nasdaq Biotechnology（NASDAQ：BIS - Get Rating）的股票持仓，根据其最近向证券交易委员会提交的文件，增加了12.5％。 该机构投资者在该时期内购买了2,335股，拥有这家公司股票的21,003股，IMC Chicago LLC拥有ProShares UltraShort Nasdaq Biotechnology约5.25％的价值，最近向证券交易委员会提交的文件显示。
Separately, UBS Group AG grew its stake in shares of ProShares UltraShort Nasdaq Biotechnology by 54.7% in the first quarter. UBS Group AG now owns 1,371 shares of the company's stock worth $33,000 after purchasing an additional 485 shares during the last quarter.
瑞银集团在第一季度将其在ProShares UltraShort Nasdaq Biotechnology的持股增加了54.7％。 UBS集团现在拥有这家公司的1,371股股票，价值33,000美元，在上个季度购买了485股。
ProShares UltraShort Nasdaq Biotechnology Stock Performance
ProShares UltraShort Nasdaq Biotechnology股票表现
ProShares UltraShort Nasdaq Biotechnology stock opened at $21.07 on Friday. ProShares UltraShort Nasdaq Biotechnology has a 52-week low of $18.37 and a 52-week high of $35.64. The firm has a 50 day moving average price of $23.69 and a two-hundred day moving average price of $25.55.
ProShares UltraShort Nasdaq Biotechnology股票周五开盘价为21.07美元。 ProShares UltraShort Nasdaq Biotechnology股票的52周最低价为18.37美元，52周最高价为35.64美元。该公司的50天移动平均股价为23.69美元，200天移动平均股价为25.55美元。
ProShares UltraShort Nasdaq Biotechnology Profile
ProShares UltraShort Nasdaq Biotechnology简介
ProShares Ultra Nasdaq Biotechnology (the Fund) seeks investment results for a single day only, not for longer periods. The Fund seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day's returns compounded over the period, which will very likely differ from twice (200%) the return of the Nasdaq Biotechnology Index (the Index) for that period.
ProShares Ultra Nasdaq Biotechnology（该基金）仅寻求单日的投资回报，而非更长时间的期间。该基金寻求在收取费用和开支前对每日表现的两倍（200％）对应的日常投资回报。 基金的收益期限长于单个交易日的结果将是将每日回报复利的结果，这很可能会与该期间纳斯达克生物技术指数（指数）的两倍（200％）的回报有所不同。
See Also
请查看
- Get a free copy of the StockNews.com research report on ProShares UltraShort Nasdaq Biotechnology (BIS)
- MarketBeat: Week in Review 10/31-11/4
- Is Hershey's a Sweet Stock to Buy After a Post-Earnings Dip?
- Datadog Doesn't Belong In The Doghouse
- Mixed Results Actually Bring More Optimism than Risk for AMD
- Nikola Shares Fall Even As EV Maker Beats Q3 Expectations
- 在StockNews.com上获得ProShares UltraShort Nasdaq Biotechnology（BIS）的免费研究报告
- MarketBeat:上周回顾10/31-11/4
- 好时（Hershey）发布季度财报后，股价下跌，是否是买入的好时机？
- Datadog不应该被冷落
- AMD的业绩表现出现参差不齐，但实际上带来的是更多的乐观情绪而不是风险
- 尽管EV制造商Nikola的第三季度业绩表现好于预期，但其股价下跌
Receive News & Ratings for ProShares UltraShort Nasdaq Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProShares UltraShort Nasdaq Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
获取ProShares UltraShort Nasdaq Biotechnology每日新闻和评级-在下面输入您的电子邮件地址，以获取最新新闻和分析师对ProShares UltraShort Nasdaq Biotechnology及相关公司的评级的简明每日摘要，MarketBeat.com的免费电子邮件新闻简报。
译文内容由第三方软件翻译。